Your session is about to expire
← Back to Search
Exercise for Sleep and Inflammation in HIV (REST Trial)
N/A
Recruiting
Research Sponsored by Christine Horvat Davey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Confirmed HIV infection
On a current, modern antiretroviral therapy (ART) (anti-retroviral regimen)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-8 weeks and 0-16 weeks
Awards & highlights
REST Trial Summary
This trial will compare the effects of two types of exercise on sleep and inflammation in older people with HIV.
Who is the study for?
This trial is for people over 50 living with HIV who have poor sleep quality, are on modern antiretroviral therapy, and lead a sedentary lifestyle. They must not have uncontrolled high blood pressure, serious heart conditions without clearance, or severe pulmonary disease requiring oxygen.Check my eligibility
What is being tested?
The study tests how two types of exercise—high-intensity interval training (HIIT) and continuous moderate-intensity exercise (CME)—affect sleep and inflammation in older adults with HIV. Participants will be randomly assigned to one of the exercise programs for 16 weeks.See study design
What are the potential side effects?
While specific side effects aren't listed for HIIT or CME, general risks may include muscle soreness, fatigue, increased heart rate during exercise, and potential exacerbation of existing health issues.
REST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am HIV positive.
Select...
I am on a modern HIV treatment regimen.
Select...
I have poor sleep quality according to the Pittsburgh Sleep Quality Index.
Select...
I am 50 years old or older.
REST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-8 weeks and 0-16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-8 weeks and 0-16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Interleukin inflammation markers
Mean sleep duration
Sleep efficiency
+2 moreSecondary outcome measures
C-reactive protein inflammation marker
Interferon gamma inflammation marker
Inflammation
REST Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: High intensity interval trainingExperimental Treatment1 Intervention
Group II: Continuous moderate intensity exerciseActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HIIT
2011
N/A
~730
Find a Location
Who is running the clinical trial?
University of WashingtonOTHER
1,740 Previous Clinical Trials
1,847,888 Total Patients Enrolled
University of Colorado, DenverOTHER
1,734 Previous Clinical Trials
2,148,833 Total Patients Enrolled
Christine Horvat DaveyLead Sponsor
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am HIV positive.I am on a modern HIV treatment regimen.I have poor sleep quality according to the Pittsburgh Sleep Quality Index.I am 50 years old or older.My blood pressure is not higher than 150/90 mmHg.I do not have unstable heart disease or serious heart rhythm problems.I need extra oxygen to breathe, even when resting or moving.I do not have severe heart failure or uncontrolled heart problems.
Research Study Groups:
This trial has the following groups:- Group 1: High intensity interval training
- Group 2: Continuous moderate intensity exercise
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment currently open to participants in this research?
"As evidenced by the details on clinicaltrials.gov, this experiment is seeking volunteers; it was first posted in October of 2021 and recently revisited during February 2022."
Answered by AI
How many patients are being recruited into this research program?
"Affirmative. According to data on clinicaltrials.gov, this medical investigation is actively attempting to find participants, having been initially posted in October of 2021 and edited as recently as February 10th 2022. The study requires 50 individuals at 2 sites for completion."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger